Annual Total Debt
$1.70 M
-$234.80 K-12.17%
December 1, 2023
Summary
- As of February 26, 2025, CSCI annual total debt is $1.70 million, with the most recent change of -$234.80 thousand (-12.17%) on December 1, 2023.
- During the last 3 years, CSCI annual total debt has fallen by -$635.50 thousand (-27.27%).
- CSCI annual total debt is now -73.30% below its all-time high of $6.35 million, reached on December 1, 1996.
Performance
CSCI Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.62 M
-$71.00 K-4.21%
September 1, 2024
Summary
- As of February 26, 2025, CSCI quarterly total debt is $1.62 million, with the most recent change of -$71.00 thousand (-4.21%) on September 1, 2024.
- Over the past year, CSCI quarterly total debt has dropped by -$79.00 thousand (-4.66%).
- CSCI quarterly total debt is now -74.66% below its all-time high of $6.38 million, reached on March 1, 1997.
Performance
CSCI Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
CSCI Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.2% | -4.7% |
| 3 y3 years | -27.3% | -4.7% |
| 5 y5 years | +263.3% | -4.7% |
CSCI Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | at low | -22.2% | +1.5% |
| 5 y | 5-year | -32.6% | at low | -35.8% | +1.5% |
| alltime | all time | -73.3% | +2287.3% | -74.7% | +2740.1% |
COSCIENS Biopharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.62 M(-4.2%) |
| Jun 2024 | - | $1.69 M(+6.0%) |
| Mar 2024 | - | $1.59 M(-6.1%) |
| Dec 2023 | $1.70 M(-12.2%) | $1.70 M(-1.7%) |
| Sep 2023 | - | $1.72 M(-6.3%) |
| Jun 2023 | - | $1.84 M(-1.7%) |
| Mar 2023 | - | $1.87 M(-3.0%) |
| Dec 2022 | $1.93 M(-7.1%) | $1.93 M(+8.5%) |
| Sep 2022 | - | $1.78 M(-8.5%) |
| Jun 2022 | - | $1.94 M(-5.8%) |
| Mar 2022 | - | $2.06 M(-0.6%) |
| Dec 2021 | $2.08 M(-10.9%) | $2.08 M(-5.4%) |
| Sep 2021 | - | $2.20 M(-5.0%) |
| Jun 2021 | - | $2.31 M(+0.2%) |
| Mar 2021 | - | $2.31 M(-1.0%) |
| Dec 2020 | $2.33 M(-7.4%) | $2.33 M(+4.2%) |
| Sep 2020 | - | $2.24 M(-0.5%) |
| Jun 2020 | - | $2.25 M(+0.3%) |
| Mar 2020 | - | $2.24 M(-10.9%) |
| Dec 2019 | $2.52 M(+439.4%) | $2.52 M(-4.2%) |
| Sep 2019 | - | $2.63 M(-3.7%) |
| Jun 2019 | - | $2.73 M(-1.9%) |
| Mar 2019 | - | $2.78 M(+495.7%) |
| Dec 2018 | $466.50 K(-61.6%) | $466.50 K(-34.3%) |
| Sep 2018 | - | $709.80 K(-16.5%) |
| Jun 2018 | - | $850.50 K(-17.3%) |
| Mar 2018 | - | $1.03 M(-15.3%) |
| Dec 2017 | $1.21 M(-35.5%) | $1.21 M(-18.5%) |
| Sep 2017 | - | $1.49 M(-7.3%) |
| Jun 2017 | - | $1.60 M(-7.1%) |
| Mar 2017 | - | $1.73 M(-8.3%) |
| Dec 2016 | $1.88 M(-41.2%) | $1.88 M(-35.0%) |
| Sep 2016 | - | $2.90 M(-6.2%) |
| Jun 2016 | - | $3.09 M(-5.1%) |
| Mar 2016 | - | $3.25 M(+1.6%) |
| Dec 2015 | $3.20 M(+7.2%) | $3.20 M(-9.0%) |
| Sep 2015 | - | $3.52 M(-6.1%) |
| Jun 2015 | - | $3.75 M(+8.9%) |
| Mar 2015 | - | $3.44 M(+15.1%) |
| Dec 2014 | $2.99 M(+3.1%) | $2.99 M(-10.6%) |
| Sep 2014 | - | $3.34 M(-9.6%) |
| Jun 2014 | - | $3.69 M(+24.3%) |
| Mar 2014 | - | $2.97 M(+2.5%) |
| Dec 2013 | $2.90 M(+211.2%) | $2.90 M(+273.2%) |
| Sep 2013 | - | $776.40 K(-3.1%) |
| Jun 2013 | - | $801.50 K(-28.8%) |
| Mar 2013 | - | $1.13 M(+20.9%) |
| Dec 2012 | $931.30 K(-12.0%) | $931.30 K(-16.9%) |
| Sep 2012 | - | $1.12 M(+1.8%) |
| Jun 2012 | - | $1.10 M(+5.4%) |
| Mar 2012 | - | $1.05 M(-1.3%) |
| Dec 2011 | $1.06 M(-37.5%) | $1.06 M(-31.7%) |
| Sep 2011 | - | $1.55 M(-8.3%) |
| Jun 2011 | - | $1.69 M(-1.4%) |
| Mar 2011 | - | $1.71 M(+1.2%) |
| Dec 2010 | $1.69 M | $1.69 M(+1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $1.67 M(+0.4%) |
| Jun 2010 | - | $1.66 M(-4.8%) |
| Mar 2010 | - | $1.75 M(+1.2%) |
| Dec 2009 | $1.72 M(+23.8%) | $1.73 M(+31.7%) |
| Sep 2009 | - | $1.31 M(+6.2%) |
| Jun 2009 | - | $1.23 M(+6.3%) |
| Mar 2009 | - | $1.16 M(-16.8%) |
| Dec 2008 | $1.39 M(-14.4%) | $1.40 M(-3.4%) |
| Sep 2008 | - | $1.44 M(-5.8%) |
| Jun 2008 | - | $1.53 M(-0.8%) |
| Mar 2008 | - | $1.55 M(-5.0%) |
| Dec 2007 | $1.63 M(+301.0%) | $1.63 M(+67.3%) |
| Sep 2007 | - | $973.40 K(+4.9%) |
| Jun 2007 | - | $928.20 K(+136.7%) |
| Mar 2007 | - | $392.10 K(-3.4%) |
| Dec 2006 | $405.80 K(-14.6%) | $405.90 K(-22.1%) |
| Sep 2006 | - | $521.30 K(+13.2%) |
| Jun 2006 | - | $460.60 K(+0.8%) |
| Mar 2006 | - | $457.00 K(-3.8%) |
| Dec 2005 | $475.00 K(-10.7%) | $475.10 K(-3.4%) |
| Sep 2005 | - | $492.00 K(+2.2%) |
| Jun 2005 | - | $481.60 K(-6.8%) |
| Mar 2005 | - | $516.70 K(-2.9%) |
| Dec 2004 | $532.20 K(+198.7%) | $532.20 K(+78.7%) |
| Sep 2004 | - | $297.90 K(+106.7%) |
| Jun 2004 | - | $144.10 K(-10.6%) |
| Mar 2004 | - | $161.20 K(-9.7%) |
| Dec 2003 | $178.20 K(-63.2%) | $178.50 K(-11.1%) |
| Sep 2003 | - | $200.80 K(-48.1%) |
| Jun 2003 | - | $386.80 K(-15.6%) |
| Mar 2003 | - | $458.30 K(-5.3%) |
| Dec 2002 | $483.70 K(+581.3%) | $484.00 K(+709.4%) |
| Sep 2002 | - | $59.80 K(-9.7%) |
| Jun 2002 | - | $66.20 K(+0.8%) |
| Mar 2002 | - | $65.70 K(-7.7%) |
| Dec 2001 | $71.00 K(-72.0%) | $71.20 K(-48.0%) |
| Sep 2001 | - | $136.90 K(+67.2%) |
| Jun 2001 | - | $81.90 K(-0.8%) |
| Mar 2001 | - | $82.60 K(-67.4%) |
| Dec 2000 | $253.40 K(-38.6%) | $253.60 K(+345.7%) |
| Sep 2000 | - | $56.90 K(-90.6%) |
| Jun 2000 | - | $607.60 K(+10.3%) |
| Mar 2000 | - | $550.80 K(+33.0%) |
| Dec 1999 | $412.90 K(+113.1%) | $414.20 K(+52.1%) |
| Sep 1999 | - | $272.40 K(+301.8%) |
| Jun 1999 | - | $67.80 K(-48.8%) |
| Mar 1999 | - | $132.50 K(-32.1%) |
| Dec 1998 | $193.80 K(-80.2%) | $195.00 K(-40.5%) |
| Sep 1998 | - | $327.50 K(-69.9%) |
| Jun 1998 | - | $1.09 M(-3.4%) |
| Mar 1998 | - | $1.13 M(+15.2%) |
| Dec 1997 | $977.10 K(-84.6%) | $978.30 K(-84.6%) |
| Sep 1997 | - | $6.37 M(+4.7%) |
| Jun 1997 | - | $6.08 M(-4.6%) |
| Mar 1997 | - | $6.38 M |
| Dec 1996 | $6.35 M | - |
FAQ
- What is COSCIENS Biopharma annual total debt?
- What is the all time high annual total debt for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual total debt year-on-year change?
- What is COSCIENS Biopharma quarterly total debt?
- What is the all time high quarterly total debt for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly total debt year-on-year change?
What is COSCIENS Biopharma annual total debt?
The current annual total debt of CSCI is $1.70 M
What is the all time high annual total debt for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual total debt is $6.35 M
What is COSCIENS Biopharma annual total debt year-on-year change?
Over the past year, CSCI annual total debt has changed by -$234.80 K (-12.17%)
What is COSCIENS Biopharma quarterly total debt?
The current quarterly total debt of CSCI is $1.62 M
What is the all time high quarterly total debt for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly total debt is $6.38 M
What is COSCIENS Biopharma quarterly total debt year-on-year change?
Over the past year, CSCI quarterly total debt has changed by -$79.00 K (-4.66%)